Cargando…

Weight loss and cystic disease progression in autosomal dominant polycystic kidney disease

Progression of autosomal dominant polycystic kidney disease (ADPKD) is modified by metabolic defects and obesity. Indeed, reduced food intake slows cyst growth in preclinical rodent studies. Here, we demonstrate the feasibility of daily caloric restriction (DCR) and intermittent fasting (IMF) in a c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hopp, Katharina, Catenacci, Victoria A., Dwivedi, Nidhi, Kline, Timothy L., Wang, Wei, You, Zhiying, Nguyen, Dustin T., Bing, Kristen, Poudyal, Bhavya, Johnson, Ginger C., Jackman, Matthew R., Miller, Marsha, Steele, Cortney N., Serkova, Natalie J., MacLean, Paul S., Nemenoff, Raphael A., Gitomer, Berenice, Chonchol, Michel, Nowak, Kristen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760407/ https://www.ncbi.nlm.nih.gov/pubmed/35059607 http://dx.doi.org/10.1016/j.isci.2021.103697

Ejemplares similares

Affected parent sex and severity of autosomal dominant polycystic kidney disease: a retrospective cohort study
por: Nowak, Kristen L., et al.
Publicado: (2018)

The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression
por: Nguyen, Dustin T., et al.
Publicado: (2023)

Metabolic profiling in children and young adults with autosomal dominant polycystic kidney disease
por: Baliga, Madhurima M., et al.
Publicado: (2021)

Curcumin therapy to treat vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease: Design and baseline characteristics of participants
por: Nowak, Kristen L., et al.
Publicado: (2020)

CD8(+) T cells modulate autosomal dominant polycystic kidney disease progression
por: Kleczko, Emily K., et al.
Publicado: (2018)

Obesity, Weight Loss, Lifestyle Interventions, and Autosomal Dominant Polycystic Kidney Disease
por: Steele, Cortney, et al.
Publicado: (2022)

Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies
por: Nowak, Kristen L., et al.
Publicado: (2021)

Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients
por: Hanudel, Mark R., et al.
Publicado: (2019)

PKD1 Compared With PKD2 Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease Studies
por: Steele, Cortney, et al.
Publicado: (2021)

Developments in the management of autosomal dominant polycystic kidney disease
por: Masoumi, Amirali, et al.
Publicado: (2008)

Immune checkpoint activity regulates polycystic kidney disease progression
por: Kleczko, Emily K., et al.
Publicado: (2023)

Sex hormones and the risk of cardiovascular disease and mortality in male and female patients with chronic kidney disease: A systematic review and meta‐analysis
por: Oh, Ester S., et al.
Publicado: (2022)

Imaging Biomarkers in Young Patients With ADPKD
por: Yang, Xinyi, et al.
Publicado: (2023)

A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney Disease
por: Perrone, Ronald D., et al.
Publicado: (2017)

Recent advances in the management of hemodialysis patients: a focus on cardiovascular disease
por: Jablonski, Kristen L., et al.
Publicado: (2014)

Cerebrovascular pulsatility index is higher in chronic kidney disease
por: Oh, Ester S., et al.
Publicado: (2023)

Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
por: Perrone, Ronald D., et al.
Publicado: (2017)

Characterization of Primary Cilia in Osteoblasts Isolated From Patients With ADPKD and CKD
por: Pereira, Renata C, et al.
Publicado: (2021)

Interleukin-1 inhibition, chronic kidney disease-mineral and bone disorder, and physical function
por: Nowak, Kristen L., et al.
Publicado: (2017)

The effect of combined calcium and cholecalciferol supplementation on bone mineral density in elderly women with moderate chronic kidney disease
por: Bosworth, Cortney, et al.
Publicado: (2012)

The Enigma of Clinical Heterogeneity Among Autosomal Recessive Polycystic Kidney Disease Siblings: PKHD1 Genotype Versus Other Genomic or Environmental Modifier
por: Meena, Priti, et al.
Publicado: (2022)

Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial
por: Andrews, Emily S., et al.
Publicado: (2018)

Utilizing magnetization transfer imaging to investigate tissue remodeling in a murine model of autosomal dominant polycystic kidney disease
por: Kline, Timothy L., et al.
Publicado: (2015)

Exercise Decreases Lipogenic Gene Expression in Adipose Tissue and Alters Adipocyte Cellularity during Weight Regain After Weight Loss
por: Giles, Erin D., et al.
Publicado: (2016)

Epidemiology of autosomal-dominant polycystic liver disease in Olmsted county
por: Suwabe, Tatsuya, et al.
Publicado: (2020)

Noncoding RNAs and neurobehavioral mechanisms in psychiatric disease
por: Kocerha, Jannet, et al.
Publicado: (2015)

Modeling Diet-Induced Obesity with Obesity-Prone Rats: Implications for Studies in Females
por: Giles, Erin D., et al.
Publicado: (2016)

Standardizing total kidney volume measurements for clinical trials of autosomal dominant polycystic kidney disease
por: Edwards, Marie E, et al.
Publicado: (2018)

Resistant starch and exercise independently attenuate weight regain on a high fat diet in a rat model of obesity
por: Higgins, Janine A, et al.
Publicado: (2011)

Arterial stiffness and kidney disease progression in the systolic blood pressure intervention trial
por: Nowak, Kristen L., et al.
Publicado: (2020)

Kidney and cystic volume imaging for disease presentation and progression in the cat autosomal dominant polycystic kidney disease large animal model
por: Yu, Yoshihiko, et al.
Publicado: (2019)

Comparison of weight loss induced by daily caloric restriction versus intermittent fasting (DRIFT) in individuals with obesity: study protocol for a 52-week randomized clinical trial
por: Ostendorf, Danielle M., et al.
Publicado: (2022)

NAFLD and Chronic Kidney Disease
por: Marcuccilli, Morgan, et al.
Publicado: (2016)

Autosomal Recessive Polycystic Kidney Disease
por: Salati, Sajad Ahmad
Publicado: (2014)

Autosomal Recessive Polycystic Kidney Disease
por: Hafer, Ashley S., et al.
Publicado: (2017)

Disordered Eating in Asian American Women: Sociocultural and Culture-Specific Predictors
por: Akoury, Liya M., et al.
Publicado: (2019)

Neurodegenerative Disease Risk in Carriers of Autosomal Recessive Disease
por: Vieira, Sophia R. L., et al.
Publicado: (2021)

Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney disease
por: Klawitter, Jelena, et al.
Publicado: (2013)

Automatic semantic segmentation of kidney cysts in MR images of patients affected by autosomal-dominant polycystic kidney disease
por: Kline, Timothy L., et al.
Publicado: (2020)

Cystin genetic variants cause autosomal recessive polycystic kidney disease associated with altered Myc expression
por: Yang, Chaozhe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8mfvvke5g4liur2f70ctmsedov